> 0 1 0 1 O
10 2 4 2 4 B-lower_bound
% 4 5 4 5 I-lower_bound
Sarcomatoid 6 17 6 17 B-cancer
or 18 20 18 20 O
desmoplastic 21 33 21 33 B-cancer
histology 34 43 34 43 I-cancer

AST 0 3 44 47 B-clinical_variable
( 4 5 48 49 O
SGOT 5 9 49 53 B-clinical_variable
) 9 10 53 54 O
or 11 13 55 57 O
ALT 14 17 58 61 B-clinical_variable
( 18 19 62 63 O
SGPT 19 23 63 67 B-clinical_variable
) 23 24 67 68 O
≤ 25 26 69 70 O
3.0 27 30 71 74 B-upper_bound
X 31 32 75 76 I-upper_bound
ULN 33 36 77 80 I-upper_bound

Absolute 0 8 81 89 B-clinical_variable
neutrophil 9 19 90 100 I-clinical_variable
count 20 25 101 106 I-clinical_variable
≥1.5 26 30 107 111 O
K 31 32 112 113 I-lower_bound
/ 32 33 113 114 I-lower_bound
mcL 33 36 114 117 I-lower_bound

Bulky 0 5 118 123 B-chronic_disease
disease 6 13 124 131 I-chronic_disease
in 14 16 132 134 O
the 17 20 135 138 O
fissure 21 28 139 146 O
preventing 29 39 147 157 O
lung 40 44 158 162 O
- 44 45 162 163 O
sparing 45 52 163 170 O
pleural 53 60 171 178 B-treatment
IMRT 61 65 179 183 I-treatment

DLCO 0 4 184 188 B-clinical_variable
> 5 6 189 190 O
40 7 9 191 193 B-lower_bound
% 9 10 193 194 I-lower_bound
predicted 11 20 195 204 O
( 21 22 205 206 O
corrected 22 31 206 215 O
for 32 35 216 219 O
Hgb 36 39 220 223 B-clinical_variable
) 39 40 223 224 O

Epithelioid 0 11 225 236 B-cancer
or 12 14 237 239 I-cancer
biphasic 15 23 240 248 I-cancer
histology 24 33 249 258 I-cancer
subtype 34 41 259 266 I-cancer

FEV1 0 4 267 271 B-clinical_variable
> 5 6 272 273 O
/= 6 8 273 275 O
35 9 11 276 278 B-lower_bound
% 11 12 278 279 I-lower_bound
( 13 14 280 281 O
corrected 14 23 281 290 O
for 24 27 291 294 O
Hgb 28 31 295 298 B-clinical_variable
) 31 32 298 299 O

For 0 3 300 303 O
patients 4 12 304 312 O
who 13 16 313 316 O
develop 17 24 317 324 O
or 25 27 325 327 O
have 28 32 328 332 O
baseline 33 41 333 341 O
clinically 42 52 342 352 O
significant 53 64 353 364 O
pleural 65 72 365 372 B-chronic_disease
effusions 73 82 373 382 I-chronic_disease
before 83 89 383 389 O
or 90 92 390 392 O
during 93 99 393 399 O
initiation 100 110 400 410 O
of 111 113 411 413 O
pemetrexed 114 124 414 424 B-treatment
therapy 125 132 425 432 I-treatment

Karnofsky 0 9 433 442 B-clinical_variable
performance 10 21 443 454 I-clinical_variable
status 22 28 455 461 I-clinical_variable
≥ 29 30 462 463 O
80 31 33 464 466 B-lower_bound
% 33 34 466 467 I-lower_bound

Men 0 3 468 471 B-gender
or 4 6 472 474 I-gender
women 7 12 475 480 I-gender
not 13 16 481 484 B-contraception_consent
using 17 22 485 490 I-contraception_consent
effective 23 32 491 500 I-contraception_consent
contraception 33 46 501 514 I-contraception_consent

No 0 2 515 517 O
acute 3 8 518 523 O
congestive 9 19 524 534 B-chronic_disease
heart 20 25 535 540 I-chronic_disease
failure 26 33 541 548 I-chronic_disease

No 0 2 549 551 O
evidence 3 11 552 560 O
of 12 14 561 563 O
metastatic 15 25 564 574 B-cancer
disease 26 33 575 582 I-cancer

Patients 0 8 583 591 O
undergoing 9 19 592 602 O
extrapleural 20 32 603 615 B-treatment
pneumonectomy 33 46 616 629 I-treatment

Patients 0 8 630 638 O
with 9 13 639 643 O
a 14 15 644 645 O
concurrent 16 26 646 656 O
active 27 33 657 663 B-cancer
malignancy 34 44 664 674 I-cancer
( 45 46 675 676 O
except 46 52 676 682 O
squamous 53 61 683 691 B-cancer
or 62 64 692 694 O
basal 65 70 695 700 B-cancer
cell 71 75 701 705 I-cancer
carcinoma 76 85 706 715 I-cancer
of 86 88 716 718 I-cancer
the 89 92 719 722 I-cancer
skin 93 97 723 727 I-cancer
) 97 98 727 728 O

Patients 0 8 729 737 O
with 9 13 738 742 O
an 14 16 743 745 O
active 17 23 746 752 B-chronic_disease
infection 24 33 753 762 I-chronic_disease
that 34 38 763 767 O
require 39 46 768 775 O
systemic 47 55 776 784 B-treatment
antibiotics 56 67 785 796 I-treatment
, 67 68 796 797 O
antiviral 69 78 798 807 B-treatment
, 78 79 807 808 O
or 80 82 809 811 O
antifungal 83 93 812 822 B-treatment
treatments 94 104 823 833 I-treatment

Patients 0 8 834 842 O
with 9 13 843 847 O
serious 14 21 848 855 O
unstable 22 30 856 864 O
medical 31 38 865 872 B-chronic_disease
illness 39 46 873 880 I-chronic_disease

Platelets 0 9 881 890 B-clinical_variable
≥100 10 14 891 895 O
K 15 16 896 897 I-lower_bound
/ 16 17 897 898 I-lower_bound
mcL 17 20 898 901 I-lower_bound

Pregnant 0 8 902 910 B-pregnancy

Presence 0 8 911 919 O
of 9 11 920 922 O
third 12 17 923 928 O
space 18 23 929 934 O
fluid 24 29 935 940 O
that 30 34 941 945 O
can 35 38 946 949 O
not 38 41 949 952 O
be 42 44 953 955 O
controlled 45 55 956 966 O
by 56 58 967 969 O
drainage 59 67 970 978 B-treatment

Prior 0 5 979 984 B-treatment
intrapleural 6 18 985 997 I-treatment
therapy 19 26 998 1005 I-treatment
( 27 28 1006 1007 O
except 28 34 1007 1013 O
pleurodesis 35 46 1014 1025 B-treatment
) 46 47 1025 1026 O
or 48 50 1027 1029 O
intrapleural 51 63 1030 1042 O
therapy 64 71 1043 1050 O
at 72 74 1051 1053 O
the 75 78 1054 1057 O
time 79 83 1058 1062 O
of 84 86 1063 1065 O
P 87 88 1066 1067 O
/ 88 89 1067 1068 O
D 89 90 1068 1069 O
( 91 92 1070 1071 O
i.e. 92 96 1071 1075 O
: 96 97 1075 1076 O
intrapleural 98 110 1077 1089 B-treatment
chemotherapy 111 123 1090 1102 I-treatment
, 123 124 1102 1103 O
photodynamic 125 137 1104 1116 B-treatment
therapy 138 145 1117 1124 I-treatment
, 145 146 1124 1125 O
intrapleural 147 159 1126 1138 B-treatment
betadine 160 168 1139 1147 I-treatment
) 168 169 1147 1148 O

Prior 0 5 1149 1154 B-treatment
nephrectomy 6 17 1155 1166 I-treatment
on 18 20 1167 1169 O
the 21 24 1170 1173 O
contralateral 25 38 1174 1187 O
side 39 43 1188 1192 O
of 44 46 1193 1195 O
MPM 47 50 1196 1199 O

Prior 0 5 1200 1205 B-treatment
thoracic 6 14 1206 1214 I-treatment
radiation 15 24 1215 1224 I-treatment
therapy 25 32 1225 1232 I-treatment
preventing 33 43 1233 1243 O
hemithoracic 44 56 1244 1256 B-treatment
pleural 57 64 1257 1264 I-treatment
IMRT 65 69 1265 1269 I-treatment

Serum 0 5 1270 1275 B-clinical_variable
total 6 11 1276 1281 I-clinical_variable
bilirubin 12 21 1282 1291 I-clinical_variable
≤ 22 23 1292 1293 O
1.5 24 27 1294 1297 B-upper_bound
X 28 29 1298 1299 I-upper_bound
ULN 30 33 1300 1303 I-upper_bound

Women 0 5 1304 1309 B-gender
of 6 8 1310 1312 O
childbearing 9 21 1313 1325 O
age 22 25 1326 1329 B-age
will 26 30 1330 1334 O
be 31 33 1335 1337 O
counseled 34 43 1338 1347 O
to 44 46 1348 1350 O
use 47 50 1351 1354 O
birth 51 56 1355 1360 O
control 57 64 1361 1368 O
while 65 70 1369 1374 O
on 71 73 1375 1377 O
this 74 78 1378 1382 O
study 79 84 1383 1388 O

Women 0 5 1389 1394 B-gender
should 6 12 1395 1401 O
not 13 16 1402 1405 O
breast 17 23 1406 1412 O
- 23 24 1412 1413 O
feed 24 28 1413 1417 O
a 29 30 1418 1419 O
baby 31 35 1420 1424 O
while 36 41 1425 1430 O
on 42 44 1431 1433 O
this 45 49 1434 1438 O
study 50 55 1439 1444 O

age 0 3 1445 1448 B-age
≥ 4 5 1449 1450 O
18 6 8 1451 1453 B-lower_bound
years 9 14 1454 1459 I-lower_bound
but 15 18 1460 1463 O
≤ 19 20 1464 1465 O
80 21 23 1466 1468 B-upper_bound
years 24 29 1469 1474 I-upper_bound
at 30 32 1475 1477 O
the 33 36 1478 1481 O
time 37 41 1482 1486 O
of 42 44 1487 1489 O
consent 45 52 1490 1497 O

at 0 2 1498 1500 O
the 3 6 1501 1504 O
participating 7 20 1505 1518 O
site 21 25 1519 1523 O
of 26 28 1524 1526 O
stage 29 34 1527 1532 B-lower_bound
I 35 36 1533 1534 I-lower_bound
- 36 37 1534 1535 O
III 37 40 1535 1538 B-upper_bound
malignant 41 50 1539 1548 B-cancer
pleural 51 58 1549 1556 I-cancer
mesothelioma 59 71 1557 1569 I-cancer

consideration 0 13 1570 1583 O
should 14 20 1584 1590 O
be 21 23 1591 1593 O
given 24 29 1594 1599 O
to 30 32 1600 1602 O
drain 33 38 1603 1608 O
the 39 42 1609 1612 O
effusion 43 51 1613 1621 O
prior 52 57 1622 1627 B-treatment
to 58 60 1628 1630 I-treatment
chemotherapy 61 73 1631 1643 I-treatment
administration 74 88 1644 1658 O

lactating 0 9 1659 1668 O
women 10 15 1669 1674 B-gender

patients 0 8 1675 1683 O
with 9 13 1684 1688 O
biphasic 14 22 1689 1697 B-cancer
histology 23 32 1698 1707 O
can 33 36 1708 1711 O
have 37 41 1712 1716 O
< 42 43 1717 1718 O
10 44 46 1719 1721 B-upper_bound
% 46 47 1721 1722 I-upper_bound
sarcomatoid 48 59 1723 1734 B-cancer

should 0 6 1735 1741 O
not 7 10 1742 1745 B-pregnancy
become 11 17 1746 1752 I-pregnancy
pregnant 18 26 1753 1761 I-pregnancy
or 27 29 1762 1764 O
father 30 36 1765 1771 O
a 37 38 1772 1773 O
baby 39 43 1774 1778 O
while 44 49 1779 1784 O
on 50 52 1785 1787 O
this 53 57 1788 1792 O
study 58 63 1793 1798 O
because 64 71 1799 1806 O
the 72 75 1807 1810 O
drugs 76 81 1811 1816 O
in 82 84 1817 1819 O
this 85 89 1820 1824 O
study 90 95 1825 1830 O

